What Role Do Regulatory Bodies Play in Quality Risk Management for Cancer Drugs?
Regulatory bodies such as the FDA and EMA play a crucial role in enforcing quality risk management practices for cancer drugs. They provide guidelines, conduct inspections, and review risk management plans submitted by pharmaceutical companies. Compliance with these regulations ensures that cancer treatments meet stringent safety and efficacy standards, protecting patients from potential harm.
